021 — Port Royal, South Carolina

021 is a clinical research site located in Port Royal, South Carolina, United States.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

021 has participated in 2 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Pharma, UCB BIOSCIENCES, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Port Royal

Browse all research sites in South Carolina · View every site in Port Royal

• Coastal Neurology
• Research Site
• Coastal Neurology PA
• US319
• TransitionTIL Investigational Site
• Neurology
• Novartis Investigative Site
• Coastal Neurology /ID# 222893
• Coastal Neurology /ID# 217190
• Coastal Neurology, P.A.
• Coastal Nurology

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 021?

021 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 021 conducted?

021 has 2 clinical trials on record. Their work covers Epilepsy.

Is 021 accredited by Crixeo Clinical Trials?

021 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 021?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.